Your Article Summary
See Latest ArticlesA review of the clinical pharmacology of methamphetamine
Addiction, 06/29/09
Cruickshank CC et al. - Repeated use may induce neurotoxicity, associated with prolonged psychiatric symptoms, cognitive impairment and an increased risk of developing Parkinson's disease. Abrupt cessation of repeated methamphetamine use leads to a withdrawal syndrome consisting of depressed mood, anxiety and sleep disturbance.
Methods- Relevant literature was identified through a PubMed search.
- Additional literature was obtained from relevant books and monographs.
- The mean elimination half-life for methamphetamine is approximately 10 hours, with considerable inter-individual variability in pharmacokinetics.
- Direct effects at low-to-moderate methamphetamine doses (5-30 mg) include arousal, positive mood, cardiac stimulation and acute improvement in cognitive domains such as attention and psychomotor coordination.
- At higher doses used typically by illicit users (≥50 mg), methamphetamine can produce psychosis.
- Its hypertensive effect can produce a number of acute and chronic cardiovascular complications.
- Acute withdrawal lasts typically for 7-10 days, and residual symptoms associated with neurotoxicity may persist for several months.
Related Articles
Methamphetamine Body Stuffers: An Observational Case Series
Annals of Emergency Medicine, 10/13/09
Relevance Score: 78%
Clinical pharmacology of analgesics in old age and frailty
Reviews in Clinical Gerontology, 11/10/09
Relevance Score: 68%
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of COPD
American Journal of Respiratory and Critical Care Medicine, 10/30/09
Relevance Score: 67%
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Journal of Clinical Oncology, 10/20/09
Relevance Score: 67%
Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohns disease
Journal of Gastroenterology, 10/06/09
Relevance Score: 67%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Statin Choice decision aid in primary care: A randomized trial
Patient Education and Counselling, 12/04/09
Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk
Cleveland Clinic Journal of Medicine, 12/04/09
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Preventing depression in high-risk groups
Current Opinion in Psychiatry, 12/04/09
Decreasing pediatric patient anxiety about radiology imaging tests: prospective evaluation of an educational intervention
Journal of Child Health Care, 12/04/09
Change in delusions is associated with change in jumping to conclusions
Psychiatry Research, 12/04/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice
Therapeutic Advances in Respiratory Disease, 12/04/09
Improving coordination of care for Aboriginal people with mental health, alcohol and drug use problems: progress report on an ongoing collaborative action research project
The Australian Journal of Primary Health, 12/03/09
Substance Use Disorder in Adolescence: A Review for the Pediatric Dentist
Journal of Dentistry for Children, 12/03/09